Scorpion anti-venom pharmaceutical drug
Ended Awarded Last action
- Contract number
- HHSI249201300030G
- Awardee
-
Rare Disease Therapeutics, Inc. UEI M7B1ABSZJKX8
- Awarding agency
-
Indian Health Service
Department of Health and Human Services
- Obligated
- $5,214
Award facts
- Contract value 100% obligated
- $5,213.60 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Sells, AZ 85634, USA
- Legislative mandates
-
- Other statutory authority
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Close Out | -$20 | |
| Original award | $5,234 |
Quick answers
Who was awarded contract HHSI249201300030G?
HHSI249201300030G was awarded to Rare Disease Therapeutics, Inc. by Indian Health Service (Department of Health and Human Services) on April 17, 2013.
How much is contract HHSI249201300030G worth?
The government has obligated $5,214 on HHSI249201300030G.
Is contract HHSI249201300030G an order under another contract?
Yes. HHSI249201300030G is a delivery order under V797P5195B, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract HHSI249201300030G competed?
The extent of competition for HHSI249201300030G was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award